SEK198.40
1.59% yesterday
Stockholm, Jun 13, 05:30 pm CET
ISIN
SE0010323311
Symbol
BIOA B
Sector
Industry

BioArctic AB Stock price

SEK198.40
+26.40 15.35% 1M
+26.60 15.48% 6M
-1.10 0.55% YTD
-27.80 12.29% 1Y
+127.70 180.62% 5Y
+169.40 584.14% 10Y
+169.40 584.14% 20Y
Stockholm, Closing price Fri, Jun 13 2025
-3.20 1.59%
ISIN
SE0010323311
Symbol
BIOA B
Sector
Industry

Key metrics

Market capitalization SEK17.85b
Enterprise Value SEK17.11b
P/E (TTM) P/E ratio 19.49
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 11.28
P/S ratio (TTM) P/S ratio 11.76
P/B ratio (TTM) P/B ratio 9.08
Revenue growth (TTM) Revenue growth 501.61%
Revenue (TTM) Revenue SEK1.52b
EBIT (operating result TTM) EBIT SEK919.85m
Free Cash Flow (TTM) Free Cash Flow SEK-190.14m
Cash position SEK788.57m
EPS (TTM) EPS SEK10.18
P/E forward 18.04
P/S forward 10.66
EV/Sales forward 10.22
Show more

Is BioArctic AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

BioArctic AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a BioArctic AB forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a BioArctic AB forecast:

Buy
80%
Hold
20%

Financial data from BioArctic AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,517 1,517
502% 502%
100%
- Direct Costs 36 36
14% 14%
2%
1,481 1,481
604% 604%
98%
- Selling and Administrative Expenses 156 156
18% 18%
10%
- Research and Development Expense 333 333
429% 429%
22%
923 923
-
61%
- Depreciation and Amortization 3.13 3.13
-
0%
EBIT (Operating Income) EBIT 920 920
860% 860%
61%
Net Profit 902 902
838% 838%
59%

In millions SEK.

Don't miss a Thing! We will send you all news about BioArctic AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors on January 24, 2003 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Gunilla Osswald
Employees 107
Founded 2000
Website www.bioarctic.se

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today